Glomerular disease

IgA nephropathy, lupus nephritis, membranous, FSGS, nephrotic syndrome and the new targeted therapies.

Weekly

Weekly · Oct 2: The Middle-Molecule Race, a Dipstick Adherence Check, and AI for Fellows

Two ways to clear more middle molecules arrive in US dialysis units at once. A urine dipstick can show whether patients are taking their SGLT2 inhibitor. Two papers disagree about who should let AI write the notes. Nine picks from the week of September 21, 2026, each with the story, the numbers…

Glomerular disease

FDA approves obinutuzumab to reduce relapse risk in childhood-onset nephrotic syndrome

The approval covers patients from age 2, including adults whose disease began in childhood. Healio's report rests on a press release and does not yet give the trial's numbers.